Search results for: rituximab

Hepatitis C Virus Infection Associated with Rheumatoid Arthritis

Lara C. Pullen, PhD | January 23, 2015

Research finds patients with chronic HCV infection more likely to develop RA, especially men

Biomarkers to Guide Diagnosis, Treatment of Rheumatic Diseases

Rick Brasington, MD | January 1, 2015

Examining the usefulness, drawbacks of current biomarkers in rheumatology and progress to develop better ones

Vaccines and Biologics: What Rheumatologists Need to Know

Kurt Ullman | December 1, 2014

How vaccines, medications and rheumatic disease-related effects on immune system interact

Cure, Effective Treatment for Lupus Nephritis Remain Elusive Despite Advances

Elena M. Massarotti, MD, & Peter H. Schur, MD | December 1, 2014

Rheumatology experts review history of LN, offer explanations for roadblocks to better therapies

Systemic Sjögrens: More Than a Sicca Disease

Pilar Brito-Zerón, MD, PhD, and Manuel Ramos-Casals, MD, PhD, on behalf of the EULAR-SS Task Force Group | November 1, 2014

Differences in its epidemiologic, clinical and immunologic features underscore need for a homogeneous diagnostic and therapeutic approach

Rheumatology Research Foundation’s Annual Investigators’ Meeting Spotlights Latest Findings

From the College, with Jeffrey Sparks, MD, MMSc | October 1, 2014

Groundbreaking research in treatments for rheumatoid arthritis, inflammatory disease discussed at Foundation’s celebrated event

Atacicept, Mavrilimumab Drug Updates, Trials, Safety Data

Michele B. Kaufman, PharmD, BCGP | September 1, 2014

Plus, rheumatology drug news, safety updates

Granulomatosis with Polyangiitis: A Case Review

Tehniat Haider, MD, Steven Hugenberg, MD, Veronica Mesquida, MD, & Mell Gutarra, MD | September 1, 2014

Diagnosis, treatment and management of refractory gastrointestinal hemorrhage in a patient with GPA

EULAR 2014: Non-Tumor Necrosis Factor Biologics Update

Thomas R. Collins | August 1, 2014

Clinical trials on rheumatology drugs, including sarilumab, show promise for patients with rheumatoid arthritis also taking methotrexate

Lupus Classification Criteria Expanded; Treat-to-Target Approach Gains Support

Gretchen Henkel | July 1, 2014

Rheumatologists at the California Rheumatology Alliance 10th Annual Medical & Scientific Meeting in San Francisco outline disease classification criteria, treat-to-target approach to lupus